Gilead Sciences Inc (NASDAQ:GILD)

65.23
Delayed Data
As of Oct 17
 -0.12 / -0.18%
Today’s Change
60.32
Today|||52-Week Range
76.29
+4.28%
Year-to-Date
3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees
Oct 13 / MotleyFool.com - Paid Partner Content
Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock
Oct 02 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Johnson & Johnson
Oct 12 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Pfizer
Sep 29 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Gilead Sciences
Oct 10 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline a Buy?
Sep 27 / MotleyFool.com - Paid Partner Content
3 Big Pharma Stocks Driving Price Inflation
Oct 10 / MotleyFool.com - Paid Partner Content
Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval
Sep 23 / Zacks.com - Paid Partner Content
3 Companies To Watch For At November’s Society for Immunotherapy of Cancer Meeting
Oct 09 / MotleyFool.com - Paid Partner Content
Merck's Two HIV Drugs Get FDA Approval for Expanded Use
Sep 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close65.35
Today’s open65.30
Day’s range64.78 - 65.69
Volume4,689,297
Average volume (3 months)6,021,484
Market cap$79.4B
Data as of 4:00pm ET, 10/17/2019

Growth & Valuation

Earnings growth (last year)+18.72%
Earnings growth (this year)+4.96%
Earnings growth (next 5 years)+3.35%
Revenue growth (last year)-15.00%
P/E ratio14.1
Price/Sales3.68
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.88+0.28%
AMGNAmgen+0.35+0.17%
BIIBBiogen-2.12-0.93%
EXASExact Sciences Corp-0.19-0.19%
Data as of 4:00pm ET, 10/17/2019

Financials

Next reporting dateOctober 25, 2019
EPS forecast (this quarter)$1.76
Annual revenue (last year)$22.2B
Annual profit (last year)$5.5B
Net profit margin24.56%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts